Cynthia M Butitta - Net Worth and Insider Trading

Cynthia M Butitta Net Worth

The estimated net worth of Cynthia M Butitta is at least $22 Million dollars as of 2024-05-13. Cynthia M Butitta is the COO of Kite Pharma Inc and owns about 121,567 shares of Kite Pharma Inc (KITE) stock worth over $22 Million. Cynthia M Butitta is also the COO and CFO of MabVax Therapeutics Holdings Inc and owns about 7 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $0. Details can be seen in Cynthia M Butitta's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cynthia M Butitta has not made any transactions after 2017-09-25 and currently still holds the listed stock(s).

Transaction Summary of Cynthia M Butitta

To

Cynthia M Butitta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cynthia M Butitta owns 5 companies in total, including UroGen Pharma Ltd (URGN) , Kite Pharma Inc (KITE) , and MabVax Therapeutics Holdings Inc (MBVXQ) among others .

Click here to see the complete history of Cynthia M Butitta’s form 4 insider trades.

Insider Ownership Summary of Cynthia M Butitta

Ticker Comapny Transaction Date Type of Owner
URGN UroGen Pharma Ltd 2019-01-01 director
KITE Kite Pharma Inc 2017-10-03 Chief Operating Officer
MBVXQ MabVax Therapeutics Holdings Inc 2009-11-18 COO and CFO
2020-11-18 director
2022-06-09 director

Cynthia M Butitta Latest Holdings Summary

Cynthia M Butitta currently owns a total of 2 stocks. Among these stocks, Cynthia M Butitta owns 121,567 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $22 Million and a weighting of 100%. Cynthia M Butitta also owns 7 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of August 10, 2006, with a value of $0 and a weighting of 0%.

Latest Holdings of Cynthia M Butitta

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KITE Kite Pharma Inc 2017-09-25 121,567 179.79 21,856,531
MBVXQ MabVax Therapeutics Holdings Inc 2006-08-10 7 0.02 0

Holding Weightings of Cynthia M Butitta


Cynthia M Butitta Form 4 Trading Tracker

According to the SEC Form 4 filings, Cynthia M Butitta has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 4,228 shares on September 25, 2017, which brought Cynthia M Butitta around $759,602.

According to the SEC Form 4 filings, Cynthia M Butitta has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the acquisition of 1 shares on August 10, 2006, which cost Cynthia M Butitta around $77,350.

Insider Trading History of Cynthia M Butitta

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cynthia M Butitta Trading Performance

GuruFocus tracks the stock performance after each of Cynthia M Butitta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cynthia M Butitta is 19.49%. GuruFocus also compares Cynthia M Butitta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cynthia M Butitta within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cynthia M Butitta's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cynthia M Butitta

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.52
Relative Return to S&P 500(%) 7.39

Cynthia M Butitta Ownership Network

Ownership Network List of Cynthia M Butitta

No Data

Ownership Network Relation of Cynthia M Butitta


Cynthia M Butitta Owned Company Details

What does UroGen Pharma Ltd do?

Who are the key executives at UroGen Pharma Ltd?

Cynthia M Butitta is the director of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , General Counsel Jason Drew Smith , and Chief Financial Officer Dong Kim .

UroGen Pharma Ltd (URGN) Insider Trades Summary

Over the past 18 months, Cynthia M Butitta made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 21,478 shares made by Mark Schoenberg , and a net sale of 15,422 shares made by Jason Drew Smith .

In summary, during the past 3 months, insiders sold 12,000 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 36,900 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 36,900 shares.

UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

UroGen Pharma Ltd Insider Transactions

No Available Data

Cynthia M Butitta Mailing Address

Above is the net worth, insider trading, and ownership report for Cynthia M Butitta. You might contact Cynthia M Butitta via mailing address: 3165 Porter Drive, Palo Alto Ca 94304.

Discussions on Cynthia M Butitta

No discussions yet.